Gadolinium(III) acetylacetonate hydrate(CAS: 14284-87-8)

Gadolinium(III) acetylacetonate hydrate (CAS: 14284-87-8) is subject to regulatory guidelines under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), which includes classification for health hazards. In the European Union, it is regulated under REACH for registration, evaluation, authorization, and restriction of chemicals. Additionally, the FDA and EPA have specific guidelines for its use in medical applications and environmental handling.

Alternatives to Gadolinium(III) acetylacetonate hydrate (CAS: 14284-87-8) in synthesis include other chelating agents like gadolinium(III) chloride hydrate or gadolinium(III) nitrate hydrate. These alternatives can be used in similar contexts but may have different solubility and reactivity properties.

The market for Gadolinium(III) acetylacetonate hydrate (CAS: 14284-87-8) is driven by its use in medical imaging, particularly in MRI contrast agents. Research trends focus on optimizing its performance and exploring its potential applications in other areas like photovoltaic materials and catalysis. Market trends show steady growth due to its essential role in healthcare diagnostics.

Waste containing Gadolinium(III) acetylacetonate hydrate (CAS: 14284-87-8) should be collected and handled according to local and international regulations. It is advisable to neutralize the waste before disposal to minimize environmental impact. Incineration or professional waste disposal services are recommended, ensuring all waste is disposed of safely to prevent contamination and comply with environmental protection standards.